General
Preferred name
TAZAROTENE
Synonyms
Tazorac ()
AGN 190168 ()
Zorac ()
Tazarotene, AGN 190168 ()
PMID27336223-Compound-10 ()
AGN190168 ()
AGN-190168 ()
ARAZLO ()
AVAGE ()
FABIOR ()
IDP-123 ()
TAZAROTENE COMPONENT OF DUOBRII ()
TAZAROTENE COMPONENT OF IDP-118 ()
TAZAROTENO ()
P&D ID
PD009714
CAS
118292-40-3
Tags
available
drug
prodrug
Approved by
FDA
First approval
1997
Drug indication
Psoriasis vulgaris
acne
Drug Status
approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Tazarotene is a vitamin A-like retinoid that binds all isoforms of the retinoic acid receptor, but may show selectivity for the β, and γ isoforms acting via which may result in altered gene expression that provides the beneficial effects on skin condition. Tazarotene is essentailly a prodrug, with tazarotenic acid (PubChem CID 147525) being the active metabolite. (GtoPdb)
PHARMACODYNAMICS Following topical application, tazarotene undergoes esterase hydrolysis to form its active metabolite, tazarotenic acid. When treating acne tazarotene may be taken in conjunction with an oral antibiotic. Tazarotene has been shown in peer-reviewed double blinded studies to reduce: mottling and hyperpigmentation, sallowness, fine wrinkling and coarse wrinkling in sun damaged skin. Histological studies have shown that long term (greater than 1 year) use of Tazarotene is associated with a significant reduction in atypical melanocytes and keratocytes - cells considered to be precursors of skin cancer. Some studies have shown long term use of Tazarotene to be associated with increased collagen production and better organization of skin collagen bundles.
DESCRIPTION Tazarotene (AGN 190168) is a selective retinoic acid receptor (RAR) agonist for the treatment of plaque psoriasis and acne vulgaris. Tazarotene is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
PRICE 37
DESCRIPTION Tazarotene is an acetylenic retinoid used to treat fine wrinkles, mottled pigmentation of the skin, acne vulgaris, and plaque psoriasis. It binds to all three members of the retinoic acid receptor (RAR) family. (Enamine Bioactive Compounds)
DESCRIPTION Tazarotene (Zorac) is a synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. (TargetMol Bioactive Compound Library)
Compound Sets
28
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
EUbOPEN Chemogenomics Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
113
Properties
(calculated by RDKit )
Molecular Weight
351.13
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
4.43
TPSA
39.19
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.59
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Member status
member
MOA
Retinoid RARgamma Agonists
Ornithine Decarboxylase Inhibitors
Retinoid RARbeta Agonists
Retinoid Receptor agonist
Indication
cosmetic, sunscreen lotion
Target
RARA, RARB, RARG, RXRB
Retinoid Receptor
RAR/RXR
RAR
Pathway
Autophagy
Metabolism
Metabolic Enzyme/Protease
Vitamin D Related/Nuclear Receptor
Therapeutic Class
Dermatologic Agents
Recommended Cell Concentration
1 uM
Source data